univasc
Pharmaranks rates Univasc 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Univasc (Moexipril Hydrochloride) is an angiotensin converting enzyme inhibitor used to treat Diabetic Nephropathies, Heart Failure, Hypertension, Left Ventricular Dysfunction.
Moexipril Hydrochloride · by Ucb Inc
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Moexipril Hydrochloride
- Drug class
- Angiotensin Converting Enzyme Inhibitor
- Form
- Tablet
- Strength
- Moexipril Hydrochloride 15MG **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons** · Moexipril Hydrochloride 7.5MG **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons**
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- diabetic nephropathies, heart failure, hypertension
- Manufacturer
- Ucb Inc
- What the pharmacy pays
- ~$29.42 for 30 — not your price
- FDA application
- NDA020312
- Availability
- Discontinued (per FDA)
Foods & drinks to be careful with
Well-established interactions for this medicine’s drug class, summarized from public health authorities. General information, not medical advice — always confirm with your pharmacist or the label.
Potassium-rich foods & salt substitutes
Watch out for: salt substitutes containing potassium, and large amounts of potassium-rich foods or supplements.
These medicines can raise blood potassium. Adding a lot of extra potassium can push it too high (hyperkalemia), which can affect the heart.
What to do: Don't use potassium-based salt substitutes unless your clinician approves, and ask before taking potassium supplements. Your clinician may check your potassium level with blood tests.
Source: Lisinopril (an ACE inhibitor) — MedlinePlus (U.S. National Library of Medicine) · Spironolactone (a potassium-sparing diuretic) — MedlinePlus (U.S. National Library of Medicine)
Drug class
May treat (source: NIH RxClass)
See how Univasc ranks — best-rated angiotensin converting enzyme inhibitor for:
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Univasc treat?
- Univasc (Moexipril Hydrochloride) may be used to treat diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Univasc rated?
- pharmaranks gives Univasc a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Univasc cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $29.42 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins. Pharmacies pay less for a same-class option, Qbrelis — about $0.77 on the same basis.
- Is there a coupon or discount for Univasc?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Univasc. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Univasc?
- Univasc is marketed by Ucb Inc. You can see Ucb Inc's full profile, rating, and other products on pharmaranks.
- Is Univasc a brand-name or generic drug?
- Univasc is a brand-name product with the active ingredient Moexipril Hydrochloride.
- Is Univasc available over the counter?
- No. Univasc is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Univasc come in?
- Univasc is currently marketed as tablet, per the FDA's National Drug Code Directory.
- What class of drug is Univasc?
- Univasc is classified as angiotensin converting enzyme inhibitor, per the FDA's Established Pharmacologic Class.
- Is Univasc FDA-registered?
- Univasc is on record with the U.S. FDA under application number NDA020312. You can verify this on its official FDA label.
- Has Univasc been recalled by the FDA?
- Univasc has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Univasc safe?
- There's no single safe-or-not verdict. pharmaranks gives Univasc a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Univasc head-to-head
Guides for this medication
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
univasc
70/100